The Exciting Future Of Probiotics In Treating Chronic Disease With Deanna Gibson, PhD | MGC Ep. 91 The Mind-Gut Conversation podcast

Content provided by Emeran Mayer, MD, Emeran Mayer, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Emeran Mayer, MD, Emeran Mayer, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

The Mind-Gut Conversation »
The Exciting Future of Probiotics in Treating Chronic Disease with Deanna Gibson, PhD | MGC Ep. 91

2d ago 48:36

MP3•Episode home

Inflammatory bowel diseases like ulcerative colitis remain among the most difficult chronic conditions to manage — but new science at the intersection of microbiome research and biotechnology may offer hope.

In this episode of The Mind-Gut Conversation, I sit down with Dr. Deanna Gibson, microbiome researcher and cofounder of Melius Microbiomics, to explore how genetically engineered microbial medicines could transform the future of IBD treatment — and what it will take for patients and the medical community to embrace them.

In this conversation, we explore:

· How Dr. Gibson’s research led to the development of BioPersist™ and BioColonize™ for IBD.

· Why new microbiome-targeted therapies are urgently needed — especially for younger patients in whom ulcerative colitis is on the rise.

· What makes BioPersist™ different from traditional probiotics and current IBD treatments.

· How genetically engineered microbial medicines (GEMMs) represent a new generation of gut therapies.

· Early research findings that support BioPersist™ as a promising treatment for ulcerative colitis.

· Challenges in gaining public trust for novel biotech therapies amid growing skepticism.

· Exciting new discoveries in microbiome science — and the future potential for live biotherapeutics beyond IBD.

If you’re curious about the exciting direction where gut health research is headed — and how the microbiome may change the way we treat chronic disease — this episode is for you.

Tune in and join the conversation!

Disclaimer: Dr. Mayer is the Chief Medical Officer of Melius Microbiomics and has been involved in the commercial development of Genetically Engineered Microbial Medicines (GEMMs).

91 episodes

#Fitness #Emeran Mayer

The Exciting Future of Probiotics in Treating Chronic Disease with Deanna Gibson, PhD | MGC Ep. 91

The Mind-Gut Conversation

published 2d ago